China Bio/Pharma Manufacturing Facilities Construction & Reconstruction

Manufacturing Life Cycle Management and Risks & Quality Control to Ensure New Chinese GMP Compliance

30 November 1 December 2011

Currently in read only mode, sorry about that, please try again in a few hours.

15 speakers

  • Bassel Iskandarani Director of GTO-Central Services of Asia Pacific, MSD International GmbH
  • Shawn Wang Head of Quality, Novartis China
  • Minfeng Xu Certification Department, Shanghai Food and Drug Packaging Material Control Centre
  • Zhijian Xiao Quality Director, AstraZeneca China
  • Todd Mabe Principal Technical Manager, Validations, Roche Singapore Technical operations
  • Lei Sun President Manufacture, Autekbio, China
  • Alex Wang Deputy General Manager, Zhejiang Hisun Pharmaceutical
  • Guangde Zhong President, Quality Association for Pharmaceuticals of Sichuan Province ; Major Drafter of Chinese New GMP
  • Jason Li Senior Director, Genor Biopharma
  • Zhenping Wu Vice President, Hutchison MediPharma
  • Xuejie Dou Quality Assurance Director, Shandong Xinhua Pharmaceutical
  • Haigen Deng Former Quality Assurance Directory, Sino Swed Pharmaceutical; Major Drafter of Chinese New GMP
  • Tao Ma Deputy General Manager, Sino-Swed Pharmaceutical
  • Michael Lee Senior Vice President, Manufacturing & Project, Shanghai Biomabs Pharmaceuticals
  • Junyou Ge Deputy General Manager, Kelun Pharmaceutical

3 sessions

Day 1 Wednesday 30th November 2011

Day 2 Thursday 1st December 2011

Friday 2nd December 2011

2 known attendees

  • IQPC Asia
  • Susy AngryanyW

Tell your friends!

Share this event with your friends on Twitter



1 write-up

Added 6 years ago

See all coverage

3 items in total


See something wrong?

Report an issue with this event